• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Novartis Receives Positive CHMP Opinion for Remibrutinib in CSU

    GLOBENEWSWIRE

    Novartis Reveals Rhapsido`s Broader Reach Beyond CSU at AAAAI

    GLOBENEWSWIRE

    Novartis` Remibrutinib First to Meet Phase III Endpoint in CIndU

    GLOBENEWSWIRE

    Novartis` Skin Disease Drug Gets Us Approval

    REUTERS

    Novartis Remibrutinib Data Confirm Efficacy And Safety In Urticaria

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.